Last update:

Oncology & Cancer news

Oncology & Cancer

AI uncovers how DNA architecture failures trigger blood cancer

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off neighborhoods from essential services. That's what happens inside cells when the 3D structure ...

Oncology & Cancer

Antibody therapy eradicates traces of multiple myeloma in preliminary trial

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted by researchers at Sylvester ...

Oncology & Cancer

Antibody halts triple-negative breast cancer in preclinical models

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with ...

Oncology & Cancer

Backup DNA repair system could be cancer's weak spot

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break—when both sides of the DNA helix are cut at once. Healthy cells can normally fix these breaks using highly ...

Oncology & Cancer

Simple urine test developed to screen bladder cancer

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed alternative to invasive ...

Oncology & Cancer

Update made to cervical cancer screening guideline

The American Cancer Society (ACS) released updated guidelines today for cervical cancer screening, reflecting advances in disease detection and accessibility in the United States. The updated guideline for women at average ...

Oncology & Cancer

Biomarkers link ER+ breast cancer to neighborhood poverty

Scientists have long known that Black women with estrogen-receptor positive breast cancer and those who live in disadvantaged neighborhoods often have more aggressive forms of the disease and poorer survival rates. However, ...

Oncology & Cancer

Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...

Oncology & Cancer

AI tool makes detection of skin cancer more accurate

Researchers at Fox Chase Cancer Center, Temple University's College of Engineering, and the Lewis Katz School of Medicine at Temple University have developed a new method that enhances the ability of artificial intelligence ...

Oncology & Cancer

A promising molecule against chemotherapy-induced neuropathies

Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, tingling and burning sensations in the feet and hands, sometimes even after treatment has ended. ...

Oncology & Cancer

Mutation yields hot new clues for treating immune 'cold' tumors

Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have achieved complete and durable remissions for thousands of people with end-stage metastatic cancers. ...

Oncology & Cancer

Why are so many millennials getting cancer?

If you're reading this, there's a good chance that you, like me, are a millennial. If so, you've probably noticed more and more cases of friends or acquaintances with diseases that you would normally associate with later ...